Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Schleicher

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Skinmed|March 20, 2019
Cutaneous Metastasis from Renal Cell CarcinomaMegha D Patel, Stephen Schleicher
Oncology (Williston Park, N.Y.)|March 30, 2023
Progressing From Disparity to Equity: Untangling the Complexities of Timely Care and the Rural Cancer ExperienceRichard L Martin, Stephen Schleicher
JAMA Oncology|December 6, 2016
Outcome Measurement in Value-Based PaymentsSamyukta Mullangi, Stephen Schleicher, Thomas W Feeley
JCO Oncology Practice|January 30, 2024
New Federal Guidance Makes It Harder for Patients With Cancer to Access DrugsSamyukta Mullangi, Anshu K Jain, Lalan Wilfong, et al.
International Journal of Dermatology|July 25, 2025
Pilomatrical Carcinoma: A Case Report and Review of the LiteratureMadison P Olexson, Darren Hohn, Hina A Sheikh, et al.
Journal of Neuro-Oncology|December 17, 2010
GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell lineAmy Dickey, Stephen Schleicher, Kathleen Leahy, et al.
Oncology (Williston Park, N.Y.)|February 1, 2024
Building Efficiency and Scaling With a Remote Genetic Counseling ProgramSmita K Rao, L Johnetta Blakely, Kate Small, et al.
JCO Oncology Practice|February 26, 2024
Practice Consolidation Among US Medical Oncologists, 2015-2022Michael Milligan, Parsa Erfani, E John Orav, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 18, 2011
Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer modelsYunguang Sun, Luigi Moretti, Nicholas J Giacalone, et al.
American Journal of Cancer Research|October 5, 2011
Harnessing the cell death pathway for targeted cancer treatmentChristina K Speirs, Misun Hwang, Sungjune Kim, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Skinmed|March 20, 2019
Cutaneous Metastasis from Renal Cell CarcinomaMegha D Patel, Stephen Schleicher
Oncology (Williston Park, N.Y.)|March 30, 2023
Progressing From Disparity to Equity: Untangling the Complexities of Timely Care and the Rural Cancer ExperienceRichard L Martin, Stephen Schleicher
JAMA Oncology|December 6, 2016
Outcome Measurement in Value-Based PaymentsSamyukta Mullangi, Stephen Schleicher, Thomas W Feeley
JCO Oncology Practice|January 30, 2024
New Federal Guidance Makes It Harder for Patients With Cancer to Access DrugsSamyukta Mullangi, Anshu K Jain, Lalan Wilfong, et al.
International Journal of Dermatology|July 25, 2025
Pilomatrical Carcinoma: A Case Report and Review of the LiteratureMadison P Olexson, Darren Hohn, Hina A Sheikh, et al.
Journal of Neuro-Oncology|December 17, 2010
GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell lineAmy Dickey, Stephen Schleicher, Kathleen Leahy, et al.
Oncology (Williston Park, N.Y.)|February 1, 2024
Building Efficiency and Scaling With a Remote Genetic Counseling ProgramSmita K Rao, L Johnetta Blakely, Kate Small, et al.
JCO Oncology Practice|February 26, 2024
Practice Consolidation Among US Medical Oncologists, 2015-2022Michael Milligan, Parsa Erfani, E John Orav, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 18, 2011
Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer modelsYunguang Sun, Luigi Moretti, Nicholas J Giacalone, et al.
American Journal of Cancer Research|October 5, 2011
Harnessing the cell death pathway for targeted cancer treatmentChristina K Speirs, Misun Hwang, Sungjune Kim, et al.
Pageof 2